Evidence map›Paper›PMID 38522910›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Superficial Primary Malignant Melanoma of the Esophagus Detected and Treated at Stage 0.

Yuzo Toyama, Ryuji Nagahama, Yu Kodama, Izumi Kaieda, Shinjiro Sakai, Gen Maeda, Hidemitsu Nishizawa, Shingo Asahara, Yuji Mizokami

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuzo ToyamaDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Ryuji NagahamaDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Yu KodamaDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Izumi KaiedaDepartment of Surgery, Kasumigaura Medical Center, Japan.
Shinjiro SakaiDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Gen MaedaDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Hidemitsu NishizawaDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Shingo AsaharaDepartment of Gastroenterology, New Tokyo Hospital, Japan.
Yuji MizokamiDepartment of Gastroenterology, New Tokyo Hospital, Japan.
New Tokyo Hospital · JPKasumigaura Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The patient was a 79-year-old male. At three years and eight months after his initial presentation, upper gastrointestinal endoscopy revealed a black-flattened elevated lesion in the middle third of the esophagus, which was diagnosed as malignant melanoma on biopsy. No lymph node or distant metastasis was found. A diagnosis of cT1bN0M0 Stage I was thus made. We performed a robot-assisted, minimally invasive esophagectomy and D2 dissection. The postoperative diagnosis was pT1a-MM, N0, M0, vascular invasion+, stage 0. The patient was recurrence-free for 14 months after surgery. We presume that an aggressive biopsy diagnosis is important for the early detection of malignant melanoma.

Indexed as

Esophageal NeoplasmsEsophagectomyMelanomaNeoplasm StagingAgedHumansMaleesophageal malignant melanomaesophageal melanosisprimary malignant melanomaStage 0

Identifiers

PMID38522910
PMCPMC11637794
OpenAlexW4393133482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.